Neurocrine Biosciences
NBIX
NBIX
125 hedge funds and large institutions have $1.05B invested in Neurocrine Biosciences in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 40 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less capital invested
Capital invested by funds: $1.12B → $1.05B (-$77.2M)
Holders
125
Holding in Top 10
2
Calls
$10M
Puts
$7M
Top Buyers
| 1 | +$13.2M | |
| 2 | +$6.07M | |
| 3 | +$5.94M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$5.38M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$4.45M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$11.5M | |
| 3 | -$3.87M | |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$3.57M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$3.43M |